Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL482545 | 1.00 | HTT (0.46) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL30494040 | 1.00 | HTT (0.46) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL14376099 | 1.00 | HTT (0.46) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL29609183 | 1.00 | HTT (0.46) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL1328402 | 1.00 | HTT (0.46) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL5117680 | 0.81 | IDO1 (0.43) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL11604556 | 0.81 | IDO1 (0.43) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL5117761 | 0.81 | IDO1 (0.43) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL3372946 | 0.81 | IDO1 (0.43) | HTTALDH1A1CYP2C19CYP3A4ALOX15 | |
| SCHEMBL3375814 | 0.81 | IDO1 (0.43) | HTTALDH1A1CYP2C19CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557836-A | Preparation method of carboxylic acid | 云南大学 | 2023-01-03 | — | — | CN | claimed |
| CN-110002961-B | Method for racemization-free synthesis of chiral alcohol | 三峡大学 | 2022-05-03 | — | — | CN | claimed |
| US-20150045564-A1 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-12 | — | — | US | claimed |
| WO-2013102935-A2 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-07-11 | — | — | WO | claimed |
| EP-1542672-A4 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | CHENG J L (US) | 2006-06-07 | — | — | EP | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-1542672-A2 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | Cheng, J. L. (US) | 2005-06-22 | — | — | EP | claimed |
| WO-2004014290-A2 | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | CHENG J L (US) | 2004-02-19 | — | — | WO | claimed |
| US-6495243-B1 | Recording substrates for ink jet printing | XEROX CORPORATION | 2002-12-17 | — | — | US | claimed |
| US-5759734-A | Method of generating simulated photographic-quality images on luminescent melt-formed backing substrates | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| US-4868344-A | OPTICALLY PURE HALOALCOHOLS | ALDRICH-BORANES, INC. (US) | 1989-09-19 | — | — | US | claimed |
| US-20250304537-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | REPARE THERAPEUTICS INC. (CA) | 2025-10-02 | — | — | US | disclosed |
| EP-4526293-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Repare Therapeutics Inc. (CA) | 2025-03-26 | — | — | EP | disclosed |
| CN-115160123-B | Method for preparing carboxylic acid compound by oxidizing alcohol by using oxygen as oxidant under catalysis of copper | 复旦大学 | 2024-07-30 | — | — | CN | disclosed |
| US-12043623-B2 | Purinones as ubiquitin-specific protease 1 inhibitors | FORMA THERAPEUTICS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-4904409-A | LIQUID CRYSTAL HAS HIGH TWISTABILITY | CHISSO CORPORATION (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0311329-A2 | Liquid crystal compositions comprising optically active 1-[2-halogen-substituted-phenyl]-ethanols and derivatives thereof | Chisso Corporation (JP) | 1989-04-12 | — | — | EP | disclosed |
| US-3980722-A | Production of bromostyrene, dibromostyrene and alkyl bromides | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-09-14 | — | — | US | disclosed |
| US-3966831-A | Production of bromostyrenes | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304537-A1 | HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | CSNK1A1, CSNK1G1, CSNK2A1 | HTT 1086/4885ALDH1A1 4490/4885CYP2C19 2763/4885 |
| US-20150045564-A1 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | SOD1, AOC2, SOD3 | HTT 669/4885ALDH1A1 97/4885CYP2C19 281/4885 |
| US-12043623-B2 | Purinones as ubiquitin-specific protease 1 inhibitors | USP1, UBA1, UBXN1 | HTT 2813/4885ALDH1A1 633/4885CYP2C19 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.